Dynavax Technologies | DVAX - Market Capitalization

Stock Price
15.51
Daily Change
0.03 0.19%
Monthly
0.65%
Yearly
17.86%
Q1 Forecast
15.01

Dynavax Technologies reported $2.03B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 371.63B 37.4B Feb/2026
Adma Biologics USD 3.49B 853M Sep/2025
Amgen USD 184.41B 32.48B Feb/2026
AstraZeneca USD 233.07B 17.56B Sep/2025
Biogen USD 20.54B 2.13B Sep/2025
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Bristol-Myers Squibb USD 91.8B 2.4B Sep/2025
Dynavax Technologies USD 1.16B 26M Sep/2025
Gilead Sciences USD 137.73B 184M Sep/2025
Glaxosmithkline GBP 106.96B 20.08B Feb/2026
Merck USD 293.38B 83.74B Feb/2026
Neurocrine Biosciences USD 13.92B 1.48B Sep/2025
Novartis USD 265.66B 9.48B Sep/2025
Pfizer USD 147.57B 12.48B Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
TG Therapeutics USD 5.74B 21M Sep/2025
Vertex Pharmaceuticals USD 100.41B 13.91B Sep/2025